Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
RationaleAlthough serotonin (5-HT) dysregulation is implicated in the pathophysiology of major depressive disorder (MDD), the role of specific receptor subtypes remains to be elucidated. Emerging preclinical research suggests an important role for the 5-HT1B receptor in behavioral regulation and depressive phenotypes. In particular, 5-HT1B heteroreceptors located within the striatum have been shown to play an essential role in antidepressant action.ObjectivesThe objective of this study was to determine 5-HT1B receptor binding potential (BPND) in the region of the ventral striatum/ventral pallidum (VS/VP) in individuals with MDD and healthy control participants.MethodsTen participants with MDD (30.8 ± 9.5 years, five men/five women) in a current major depressive episode (MDE) and ten healthy control participants (30.7 ± 10.5 years, five men/five women) underwent positron emission tomography (PET) scanning with the selective 5-HT1B receptor radioligand [11C]P943.ResultsWithin the VS/VP region of interest, [11C]P943 BPND was significantly reduced in the MDD group compared with the healthy control group (1.37 ± 0.13 and 1.68 ± 0.16, respectively; 18.7% between-group difference; p < 0.001).ConclusionsConsistent with preclinical and postmortem data, our findings suggest abnormally reduced function of VS/VP 5-HT1B receptors in humans with MDD. Abnormal 5-HT1B heteroreceptor function may contribute to dysfunctional reward signaling within the striatum, including the nucleus accumbens, via interaction with dopamine, γ-amino-butyric acid, or glutamate systems. Our findings suggest reduced 5-HT1B receptor signaling in the VS/VP in MDD and contribute to the therapeutic rationale for testing 5-HT1B agonists as a novel class of antidepressants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738 · cited 1×
“Smoking status was assessed with the Fagerstrom Test for Nicotine Dependence (FTND) (Heatherton et al. 1991); family history of depression was assessed using a modified version of the Family Interview for Genetic Studies (FIGS) (Maxwell 1992).”
MethodThe molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889 · cited 4×
“(Sari 2004) and the prominent role of this region in neurocircuitry models of depression (Nestler and Carlezon 2006; Krishnan and Nestler 2008; Carlezon and Thomas 2009).”
BackgroundMethodInfluentialBelmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059 · cited 4×
“cortex (PFC) and hippocampus ( Nestler and Carlezon 2006 ).”
BackgroundInfluentialConsensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Houle, S., Huang, S.-C., Ichise, M., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600493 · Cited by 1,955
Structured Clinical Interview for DSM-III-R Personality Disorders
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (2012) · PsycTESTS Dataset · doi:10.1037/t07827-000 · Cited by 1,403
Pizzagalli, D. A., Holmes, A. J., Dillon, D. G., Goetz, E. L., Birk, J. L., Bogdan, R., Dougherty, D. D., Iosifescu, D. V., Rauch, S. L., & Fava, M. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08081201 · Cited by 1,232
Molecular biology of 5-HT receptors
Hannon, J., & Hoyer, D. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.03.020 · Cited by 815
Pet imaging of serotonin 1A receptor binding in depression
Drevets, W. C., Frank, E., Price, J. C., Kupfer, D. J., Holt, D., Greer, P. J., Huang, Y., Gautier, C., & Mathis, C. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00189-4 · Cited by 666 · cited 2×
“2007) within a cortico-limbic-striatal circuit during both acute depressive episode and remission (Drevets et al. 1999; Bhagwagar et al. 2004; Drevets et al. 2007; Savitz et al. 2009).”
Background
Research works printed but not linked: 24
- aan het Rot M, Mathew SJ, Charney DS (2009) Neurobiological mechanisms in major depressive disorder. CMAJ 180:305–313. doi: 10.1503/cmaj.080697 · DOI · Paper page
- American Psychiatric Association. Task Force on DSM-IV (2000) Diagnostic and statistical manual of mental disorders: DSM-IV-TR. American Psychiatric Association, Washington
- Bhagwagar Z, Rabiner EA, Sargent PA, Grasby PM, Cowen PJ (2004) Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol Psychiatry 9:386–392. doi: 10.1038/sj.mp.4001401 · DOI · Paper page
- Brody AL, Olmstead RE, Abrams AL, Costello MR, Khan A, Kozman D, Saxena S, Farahi J, London ED, Mandelkern MA (2009) Effect of a history of major depressive disorder on smoking-induced dopamine release. Biol Psychiatry 66:898–901. doi: 10.1016/j.biopsych.2009.06.011 · DOI
- Chenu F, David DJ, Leroux-Nicollet I, Le Maitre E, Gardier AM, Bourin M (2008) Serotonin1B heteroreceptor activation induces an antidepressant-like effect in mice with an alteration of the serotonergic system. J Psychiatry Neurosci 33:541–550
- Cleare AJ, Murray RM, Sherwood RA, O’Keane V (1998) Abnormal 5-HT1D receptor function in major depression: a neuropharmacological challenge study using sumatriptan. Psychol Med 28:295–300 · DOI
- Gallezot JD, Nabulsi N, Neumeister A, Planeta-Wilson B, Williams WA, Singhal T, Kim S, Maguire RP, McCarthy T, Frost JJ, Huang Y, Ding YS, Carson RE (2010) Kinetic modeling of the serotonin 5-HT(1B) receptor radioligand [(11)C]P943 in humans. J Cereb Blood Flow Metab 30:196–210. doi: 10.1038/jcbfm.2009.195 · DOI · Paper page
- Heninger GR, Charney DS, Sternberg DE (1984) Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects. Arch Gen Psychiatry 41:398–402 · DOI · Paper page
- Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533–554 · DOI · Paper page
- Hu J, Henry S, Gallezot JD, Ropchan J, Neumaier JF, Potenza MN, Sinha R, Krystal JH, Huang Y, Ding YS, Carson RE, Neumeister A (2010) Serotonin 1B receptor imaging in alcohol dependence. Biol Psychiatry. doi: 10.1016/j.biopsych.2009.12.028 · DOI · Paper page
- Ichise M, Liow JS, Lu JQ, Takano A, Model K, Toyama H, Suhara T, Suzuki K, Innis RB, Carson RE (2003) Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 23:1096–1112. doi: 10.1097/01.WCB.0000085441.37552.CA · DOI · Paper page
- Jans LA, Riedel WJ, Markus CR, Blokland A (2007) Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry 12:522–543. doi: 10.1038/sj.mp.4001920 · DOI · Paper page
- Meyer JH, McNeely HE, Sagrati S, Boovariwala A, Martin K, Verhoeff NP, Wilson AA, Houle S (2006) Elevated putamen D(2) receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography study. Am J Psychiatry 163:1594–1602. doi: 10.1176/appi.ajp.163.9.1594 · DOI
- Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389 · DOI · Paper page
- Nabulsi N, Huang Y, Weinzimmer D, Ropchan J, Frost JJ, McCarthy T, Carson RE, Ding YS (2010) High-resolution imaging of brain 5-HT 1B receptors in the rhesus monkey using [11C]P943. Nucl Med Biol 37:205–214. doi: 10.1016/j.nucmedbio.2009.10.007 · DOI · Paper page
- Pauwels PJ (1997) 5-HT 1B/D receptor antagonists. Gen Pharmacol 29:293–303 · DOI
- Ruf BM, Bhagwagar Z (2009) The 5-HT(1B) receptor: a novel target for the pathophysiology of depression. Curr Drug Targets 10:1118–1138 · DOI · Paper page
- Sari Y (2004) Serotonin1B receptors: from protein to physiological function and behavior. Neurosci Biobehav Rev 28:565–582. doi: 10.1016/j.neubiorev.2004.08.008 · DOI · Paper page
- Savitz J, Lucki I, Drevets WC (2009) 5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol 88:17–31. doi: 10.1016/j.pneurobio.2009.01.009 · DOI · Paper page
- Tatarczynska E, Klodzinska A, Stachowicz K, Chojnacka-Wojcik E (2004) Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression. Behav Pharmacol 15:523–534 · DOI · Paper page
- Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273–289. doi: 10.1006/nimg.2001.0978 · DOI · Paper page
- Varnas K, Hurd YL, Hall H (2005) Regional expression of 5-HT1B receptor mRNA in the human brain. Synapse 56:21–28. doi: 10.1002/syn.20128 · DOI · Paper page
- Whale R, Clifford EM, Bhagwagar Z, Cowen PJ (2001) Decreased sensitivity of 5-HT(1D) receptors in melancholic depression. Br J Psychiatry 178:454–457 · DOI · Paper page
- Yan QS, Yan SE (2001) Activation of 5-HT(1B/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study. Eur J Pharmacol 418:55–64 · DOI
Cited by
Hansen, J. Y., Shafiei, G., Markello, R. D., Smart, K., Cox, S. M. L., Nørgaard, M., Beliveau, V., Wu, Y., Gallezot, J.-D., Aumont, É., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01186-3 · Cited by 797
Self-citationThe neurobiology of aggression and violence
Rosell, D. R., & Siever, L. J. (2015) · CNS Spectrums · doi:10.1017/s109285291500019x · Cited by 440
McIntyre, R. S., Lophaven, S., & Olsen, C. K. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000546 · Cited by 433
The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors
Root, D. H., Melendez, R. I., Zaborszky, L., & Napier, T. C. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.03.005 · Cited by 353
Dysfunctional reward processing in depression
Admon, R., & Pizzagalli, D. A. (2015) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2014.12.011 · Cited by 343
“In humans, recent studies have associated depression with reduced serotonin receptor binding potential in the striatum [37], as well as reduced glutamate [38] and GABA [39] concentration in the prefrontal cortex, with the latter study implicating reduced GABA specifically in anhedonic depression.”
Background
Metadata
- Authors
- Murrough, J. W., Henry, S., Hu, J., Gallezot, J.-D., Planeta-Wilson, B., Neumaier, J. F., & Neumeister, A.
- Venue
- Psychopharmacology
- Published
- 2010-05-18
- Volume
- 213
- Issue
- 2-3
- Pages
- 547-553
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2034199885
- Cited by
- 154
- References
- 17
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder. https://app.cochat.ai/papers/10.1007/s00213-010-1881-0
- The paper
- Murrough, J. W., Henry, S., Hu, J., Gallezot, J.-D., Planeta-Wilson, B., Neumaier, J. F., & Neumeister, A. (2011). Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder. Psychopharmacology. https://doi.org/10.1007/s00213-010-1881-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.